Inter Pharma (Thailand) Investor Sentiment

IP Stock  THB 3.18  0.54  14.52%   
About 61% of Inter Pharma's investor base is looking to short. The analysis of current outlook of investing in Inter Pharma Public suggests that many traders are alarmed regarding Inter Pharma's prospects. Inter Pharma's investing sentiment shows overall attitude of investors towards Inter Pharma Public.
  
over two weeks ago at news.google.com         
Inter-state Palladium on carbon theft uncovered after multi-crore pharma heist in Sangareddy - The H...
Google News at Macroaxis
over a month ago at news.google.com         
Nuvectis Pharma, Inc. Announces Underwritten Public Offering of Common Stock - Nasdaq
Google News at Macroaxis
over a month ago at news.google.com         
Wilson Sonsini Advises Ascentage Pharma on U.S. Initial Public Offering and Nasdaq Listing - Wilson ...
Google News at Macroaxis
over three months ago at news.google.com         
Rocket Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock - Business Wire
Google News at Macroaxis
over three months ago at news.google.com         
Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months E...
Google News at Macroaxis
over three months ago at news.google.com         
Shareholder Alert Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to It...
Google News at Macroaxis
over six months ago at news.google.com         
DCGI suspends permission to Entod pharmas eye drop, company to challenge order in court - The Econom...
Google News at Macroaxis
over six months ago at news.google.com         
Inter Pharma acquires 60 percent of METTA shares for 111.43 million baht, enters medical equipment a...
Google News at Macroaxis
over six months ago at news.google.com         
Interarch Building Products IPO Company raises Rs 179 crore from anchor investors ahead of issue - T...
Google News at Macroaxis
over six months ago at news.google.com         
IP Rises 2 percent after Moving Up to SET Index - KAOHOON INTERNATIONAL
Google News at Macroaxis
over six months ago at news.google.com         
Akums Drugs and Pharma IPO Pharma company raises 828.78 crore from anchor investors ahead of public ...
Google News at Macroaxis
over six months ago at news.google.com         
NovaBay Pharmaceuticals Announces Pricing of 3.5 Million Underwritten Public Offering - Business Wir...
Google News at Macroaxis
over six months ago at news.google.com         
Aurobindo Pharma shares hit all-time high as firm to consider buyback proposal this week - Upstox
Google News at Macroaxis
over six months ago at news.google.com         
MARKET PULSE-Gigamon, InterCloud, James River, Ohr Pharmaceutical - Reuters
Google News at Macroaxis
over six months ago at news.google.com         
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants - Busi...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Inter Pharma that are available to investors today. That information is available publicly through Inter media outlets and privately through word of mouth or via Inter internal channels. However, regardless of the origin, that massive amount of Inter data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Inter Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Inter Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Inter Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Inter Pharma alpha.

Inter Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Other Information on Investing in Inter Stock

Inter Pharma financial ratios help investors to determine whether Inter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inter with respect to the benefits of owning Inter Pharma security.